In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Series D brings in $42.5mm for Pathway Medical Technologies

Executive Summary

Pathway Medical Technologies (developing medical devices for arterial disease) has raised $40mm through its Series D venture round. Returning backer Forbion Capital Partners led the financing and was joined by fellow shareholders Giza Venture Capital, HLM Venture Partners, Latterell Venture Partners, Oxford Bioscience Partners, and some undisclosed individual investors.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register